Study shows link between prostate drugs and reduced DBL risk  

A study published in Neurology has shown a link between the use of α-1 blockers, a type of drug used to treat urinary symptoms in men with an enlarged prostate, and a lower risk of developing dementia with Lewy bodies (DBL), with a risk reduction of about 40% when compared with men taking other prostate drugs. 

You can read about this study in Neurology here: 

These findings align with a study published in the Jama Network in 2021, which suggested that the same type of drugs also lower the risk of developing Parkinson’s disease, which has similarities to DBL. 

You can read about the 2021 study in Jama Network here: